← Leaderboards
Donald L Morton
John Wayne Cancer Institute
$20,085,525
Attributed
$20,085,525
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $11.7M · FY2005–13$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$136,040,692 · 9
By mechanism
P01$131,883,323 · 8
R01$4,157,369 · 1
Top collaborators
No co-investigators on record.
Most similar at John Wayne Cancer Institute
Same institution · by research overlap
- Dave S B Hoon$13,127,002
- Robert M Elashoff$19,731,308
- Alistair J Cochran$1,667,088
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaHuman Therapy EvaluationClinical ResearchNeoplasm /Cancer SurgeryMetastasisNeoplasm /Cancer VaccineNeoplasm /Cancer ImmunotherapyMolecularMulticenter TrialsHuman SubjectFollow-UpProgramsOperative Surgical ProceduresLymph Node ExcisionSerumSpecimenClinical TrialsPrimary NeoplasmLymphadenectomyPrognosticMalignant NeoplasmsInternationalNovel StrategiesGrant
Grant awards (48)
New Approaches to Surgical Oncology$5,771,573
P01 · FY2013 · CA · contact PI
New Surgical Approaches For The Management Of Malignant Melanoma$1,742,973
P01 · FY2013 · CA · contact PI
Administration And Multicenter Trial Operations Center$1,426,939
P01 · FY2013 · CA · contact PI
New Approaches to Surgical Oncology$6,386,327
P01 · FY2012 · CA · contact PI
New Surgical Approaches For The Management Of Malignant Melanoma$1,871,173
P01 · FY2012 · CA · contact PI
Administration And Multicenter Trial Operations Center$1,513,430
P01 · FY2012 · CA · contact PI
New Approaches to Surgical Oncology$6,695,670
P01 · FY2011 · CA · contact PI
New Surgical Approaches For The Management Of Malignant Melanoma$2,105,174
P01 · FY2011 · CA · contact PI
Administration And Multicenter Trial Operations Center$1,455,546
P01 · FY2011 · CA · contact PI
New Approaches to Surgical Oncology$7,266,666
P01 · FY2010 · CA · contact PI
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$1,074,235
P01 · FY2010 · CA · contact PI
New Approaches to Surgical Oncology$7,092,691
P01 · FY2009 · CA · contact PI
Surgery, Immunology and Immunotherapy of Human Cancer$2,005,765
P01 · FY2009 · CA · contact PI
NEW APPROACHES TO SURGICAL ONCOLOGY$2,454,143
P01 · FY2008 · CA · contact PI
Project 3: New Surgical Approaches for the Management of Malignant Melanoma$1,277,949
P01 · FY2008 · CA · contact PI
Core C: Administrative Service and Multicenter Trial Operations Center$598,710
P01 · FY2008 · CA · contact PI
NEW APPROACHES TO SURGICAL ONCOLOGY$6,468,908
P01 · FY2007 · CA · contact PI
NEW APPROACHES TO SURGICAL ONCOLOGY$6,482,954
P01 · FY2006 · CA · contact PI
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$5,257,001
P01 · FY2006 · CA · contact PI
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$5,456,450
P01 · FY2005 · CA
NEW APPROACHES TO SURGICAL ONCOLOGY$3,802,077
P01 · FY2005 · CA
NEW APPROACHES TO SURGICAL ONCOLOGY$6,243,262
P01 · FY2004 · CA
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$5,176,856
P01 · FY2004 · CA
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$85,464
P01 · FY2004 · CA
NEW APPROACHES TO SURGICAL ONCOLOGY$5,981,524
P01 · FY2003 · CA
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$5,629,340
P01 · FY2003 · CA
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$83,304
P01 · FY2003 · CA
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$5,170,798
P01 · FY2002 · CA
NEW APPROACHES TO SURGICAL ONCOLOGY$3,217,430
P01 · FY2002 · CA
POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA$1,108,592
R01 · FY2002 · CA
NEW SURGICAL APPROACHES FOR THE MANAGEMENT OF MALIGNANT MELANOMA$78,870
P01 · FY2002 · CA
CORE--MULTICENTER TRIAL OPERATIONS CENTER$53,375
P01 · FY2002 · CA
ACTIVE SPECIFIC IMMUNOTHERAPY FOR MELANOMA$53,375
P01 · FY2002 · CA
SURGERY IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$4,704,543
P01 · FY2001 · CA
NEW APPROACHES TO SURGICAL ONCOLOGY$2,382,667
P01 · FY2001 · CA
POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA$1,080,112
R01 · FY2001 · CA
NEW APPROACHES TO SURGICAL ONCOLOGY$866,199
P01 · FY2001 · CA
NEW SURGICAL APPROACHES FOR THE MANAGEMENT OF MALIGNANT MELANOMA$794,109
P01 · FY2001 · CA
POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA$280,245
R01 · FY2001 · CA
CORE--CLINICAL SUPPORT SERVICES$53,375
P01 · FY2001 · CA
CLINICAL INVESTIGATION OF ACTIVE SPECIFIC IMMUNOTHERAPY OF MALIGNANT MELANOMA$53,375
P01 · FY2001 · CA
NEW SURGICAL APPROACHES FOR THE MANAGEMENT OF MALIGNANT MELANOMA$0
P01 · FY2001 · CA
SURGERY IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER$6,155,521
P01 · FY2000 · CA
NEW APPROACHES TO SURGICAL ONCOLOGY$4,043,799
P01 · FY2000 · CA
POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA$1,688,420
R01 · FY2000 · CA
CORE--CLINICAL SUPPORT SERVICES$1,027,837
P01 · FY2000 · CA
CLINICAL INVESTIGATION OF ACTIVE SPECIFIC IMMUNOTHERAPY OF MALIGNANT MELANOMA$1,027,837
P01 · FY2000 · CA
NEW SURGICAL APPROACHES FOR THE MANAGEMENT OF MALIGNANT MELANOMA$794,109
P01 · FY2000 · CA